ENTITY
Jw Pharmaceutical

Jw Pharmaceutical (001060 KS)

38
Analysis
Health Care • South Korea
JW Pharmaceutical Corp manufactures prescription and over-the counter drugs. The Company produces transfusion fluids, antibiotics, anesthetics, and respiratory and circulatory medications.
more
bullish•Jw Pharmaceutical
•11 Aug 2026 08:09

Primer: Jw Pharmaceutical (001060 KS) - Aug 2026

JW Pharmaceutical is a well-established South Korean pharmaceutical company with a dominant position in the domestic intravenous (IV) solutions...

Share
bullish•Cross Asset Strategy
•25 Sep 2024 01:56

Korea Value Up Index - Surprising Inclusions and Exclusions

There are many surprising inclusions and exclusions in the Korea Value Up Index. We provide 30 companies that are surprising inclusions and 10...

Logo
1.6k Views
Share
•12 Apr 2026 08:30

APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia

Wuxi XDC inked deal with Akari Therapeutics. Xuanzhu Bio entered licensing deal with Boston Oncology. Shionogi secured $119M BARDA contract for...

Logo
344 Views
Share
•06 Jul 2025 08:30

APAC Healthcare Weekly (July 6)- Shionogi, Simcere, Wuxi XDC, Sino Bio, Apollo Hosp, Torrent Pharma

Simcere, CSPC, and Sino Bio got approvals for their new drugs in China. Apollo Hospital announced a demerger. Torrent is acquiring controlling...

Logo
870 Views
Share
•10 Nov 2024 07:30

APAC Healthcare Weekly (Nov 10)- Alteogen, Santen Pharmaceutical, Beigene, Sun Pharmaceutical

​Alteogen partners with Daiichi Sankyo for Enhertu, Volpara secures $7.3M contract, Santen launches Rhopressa in South Korea, Sun Pharma's Leqselvi...

Logo
1.1k Views
Share
x